Thomas & Betts
What analysts say:
- Buy, sell, or hold?: Analysts are bullish on this stock with eight analysts rating it as a buy and only one rating it as a sell. Analysts like Thomas & Betts better than competitor Molex overall. While analysts still rate the stock a moderate buy, they are a little more optimistic about it compared to three months ago.
- Revenue Forecasts: On average, analysts predict $589.4 million in revenue this quarter. That would represent a rise of 10.7% from the year-ago quarter.
- Wall Street Earnings Expectations: The average analyst estimate is earnings of $0.89 per share. Estimates range from $0.86 to $0.92.
What our community says:
CAPS All-Stars are solidly backing the stock, with 98.8% granting it an "outperform" rating. The greater community backs the All-Stars, as 96.9% give it a rating of "outperform." Fools are impressed with Thomas & Betts, though the message boards have been quiet lately with only 67 posts in the past 30 days. Thomas & Betts has a bullish CAPS rating of five out of five stars that is about on par with the Fool community assessment.
Management:
Thomas & Betts' profit has risen year-over-year by an average of 31.8% over the past five quarters. Revenue has now gone up for three straight quarters.
Quarter | Q3 | Q2 | Q1 | Q4 |
Gross Margin | 31.7% | 30.0% | 31.3% | 30.3% |
Operating Margin | 13.4% | 12.5% | 11.4% | 9.3% |
Net Margin | 9.0% | 7.7% | 6.8% | 8.2% |
One final thing: If you want to keep tabs on Thomas & Betts movements, and for more analysis on the company, make sure you add it to your Watchlist.